193 related articles for article (PubMed ID: 9097712)
21. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
[TBL] [Abstract][Full Text] [Related]
22. Value of AgNORS in fine needle aspiration cytology of breast lesions.
Rajeevan K; Aravindan KP; Kumari BC
Indian J Pathol Microbiol; 1995 Jan; 38(1):17-24. PubMed ID: 8919465
[TBL] [Abstract][Full Text] [Related]
23. Nucleolar organizer regions (AgNOR) and subepithelial vascularization as field cancerization markers in oral mucosa biopsies of alcoholic and smoking patients.
López-Blanc SA; Collet AM; Gandolfo MS; Femopase F; Hernández SL; Tomasi VH; Paparella ML; Itoiz ME
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Nov; 108(5):747-53. PubMed ID: 19748291
[TBL] [Abstract][Full Text] [Related]
24. Nucleolar organizer regions in superficial spreading melanoma with nodule.
Albrecht S; Jambrosic JA; Kahn HJ
Mod Pathol; 1989 Nov; 2(6):666-70. PubMed ID: 2587571
[TBL] [Abstract][Full Text] [Related]
25. AgNOR quantification with special reference to staining patterns.
Rüschoff J; Fauser G; Knüchel R; Hofstädter F
Zentralbl Pathol; 1994 Mar; 140(1):23-30. PubMed ID: 7515669
[TBL] [Abstract][Full Text] [Related]
26. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
[TBL] [Abstract][Full Text] [Related]
27. Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues.
Ofner D; Bankfalvi A; Riehemann K; Bier B; Böcker W; Schmid KW
Mod Pathol; 1994 Dec; 7(9):946-50. PubMed ID: 7892164
[TBL] [Abstract][Full Text] [Related]
28. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
[TBL] [Abstract][Full Text] [Related]
29. Demonstration of the nucleolar organizer region by silver staining (AgNOR method) in research and in histopathological practice.
Kodousek R; Dusek J
Acta Univ Palacki Olomuc Fac Med; 1991; 131():9-37. PubMed ID: 1726500
[TBL] [Abstract][Full Text] [Related]
30. Nucleolar organizer regions (NORs) in the cells of normal mucosa and tumors of human colon.
Zaczek M; Nowakowa K; Szoł W; Chłap Z
Patol Pol; 1991; 42(2):63-7. PubMed ID: 1845397
[TBL] [Abstract][Full Text] [Related]
31. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
32. The study of AgNOR proteins in leukemias: diagnostic value and correlation to S-phase cell fraction.
Klobusická M; Babusíková O; Mesárosová A; Kusenda J; Glasová M
Neoplasma; 1996; 43(6):397-401. PubMed ID: 8996564
[TBL] [Abstract][Full Text] [Related]
33. Modified silver staining of nucleolar organizer regions to improve the accuracy of image analysis.
Orrea SC; Tomasi VH; Schwint AE; Itoiz ME
Biotech Histochem; 2001 Mar; 76(2):67-73. PubMed ID: 11440307
[TBL] [Abstract][Full Text] [Related]
34. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
35. Use of nucleolar organizer regions in the histopathological diagnosis of colorectal epithelial neoplasia.
Chida T; Ajioka Y; Watanabe H
Jpn J Clin Oncol; 1992 Apr; 22(2):73-8. PubMed ID: 1377759
[TBL] [Abstract][Full Text] [Related]
36. AgNOR and breast cancer. A study by image analysis.
Ronco A; Larran J; López A; Vilches J
Histol Histopathol; 1994 Apr; 9(2):309-13. PubMed ID: 8075491
[TBL] [Abstract][Full Text] [Related]
37. Quantitative evaluation of AgNORs in bone tumours.
Arora B; Jindal K; Kumar S; Rekhi B; Arora H; Arora DR
Pathology; 2003 Apr; 35(2):106-8. PubMed ID: 12745456
[TBL] [Abstract][Full Text] [Related]
38. Interphase AgNOR quantity and DNA content in endometrial adenocarcinoma.
Trerè D; Melchiorri C; Chieco P; Marabini A; Derenzini M
Gynecol Oncol; 1994 May; 53(2):202-7. PubMed ID: 8188080
[TBL] [Abstract][Full Text] [Related]
39. Argyrophil organizer region proteins (AgNORs) in adenohypophysial cells and adenomas of the human pituitary.
Stefaneanu L; Horvath E; Kovacs K
Mod Pathol; 1989 May; 2(3):192-9. PubMed ID: 2474815
[TBL] [Abstract][Full Text] [Related]
40. Value of AgNOR counts and morphometric analysis of nuclear parameters in premalignant and malignant lesions of the uterine cervix.
Wierzchniewska A; Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 1998; 49(4):297-301. PubMed ID: 10323085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
